# Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)

> **NCT02808364** · PHASE1 · COMPLETED · sponsor: **Guangdong 999 Brain Hospital** · enrollment: 10 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **BIOLOGICAL:** Personalized cellular vaccine

## Key facts

- **NCT ID:** NCT02808364
- **Lead sponsor:** Guangdong 999 Brain Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-01
- **Primary completion:** 2017-10-31
- **Final completion:** 2019-06-30
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2022-05-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02808364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02808364, "Personalized Cellular Vaccine for Recurrent Glioblastoma (PERCELLVAC2)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02808364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*